Jiangqian Huang
Research Subjects
Jiangqian Huang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Wenhui Yang
1 shared publicationXulin Zhou
1 shared publicationYuning Gu
1 shared publication- Zhaofeng Liang
Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213017, P.R. China
1 shared publication Zihan Gao
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Exosome-like nanoparticles derived from Sarcandra glabra regulate the Wnt pathway to intervene in the progression of gastric cancer
Gastric cancer remains a leading global malignancy, necessitating the development of novel therapeutic approaches. Plant-derived exosome-like nanoparticles have emerged as promising therapeutic vehicles due to their high biocompatibility and low immunogenicity; however, the potential anti-gastric cancer effects of Sarcandra glabra-derived exosome-like nanoparticles (SELNs) have not been previously investigated. Given the central role of Wnt/β-catenin signaling in driving gastric cancer progression, we investigated whether SELNs exert antitumor effects by modulating this axis. SELNs were isolated via differential ultracentrifugation, and their efficacy and underlying mechanisms were evaluated using a combination of in vitro functional assays and in vivo xenograft models. We found that SELNs significantly inhibited gastric cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition, while promoting apoptosis. In vivo administration of SELNs effectively suppressed tumor growth. Mechanistically, SELNs impaired the protein stability and nuclear translocation of β-catenin, which subsequently downregulated its downstream targets, c-Myc and Cyclin D1. Furthermore, SELNs sensitized gastric cancer cells to cisplatin, demonstrating a synergistic suppression of Wnt pathway activity. In conclusion, this study revealed that SELNs exert multifaceted anti-gastric cancer effects by targeting the Wnt/β-catenin pathway and can sensitize cancer cells to chemotherapy, providing a novel natural nanotherapeutic strategy for gastric cancer treatment.
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessExosome-like nanoparticles derived from Sarcandra glabra regulate the Wnt pathway to intervene in the progression of gastric cancer
Gastric cancer remains a leading global malignancy, necessitating the development of novel therapeutic approaches. Plant-derived exosome-like nanoparticles have emerged as promising therapeutic vehicles due to their high biocompatibility and low immunogenicity; however, the potential anti-gastric cancer effects of Sarcandra glabra-derived exosome-like nanoparticles (SELNs) have not been previously investigated. Given the central role of Wnt/β-catenin signaling in driving gastric cancer progression, we investigated whether SELNs exert antitumor effects by modulating this axis. SELNs were isolated via differential ultracentrifugation, and their efficacy and underlying mechanisms were evaluated using a combination of in vitro functional assays and in vivo xenograft models. We found that SELNs significantly inhibited gastric cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition, while promoting apoptosis. In vivo administration of SELNs effectively suppressed tumor growth. Mechanistically, SELNs impaired the protein stability and nuclear translocation of β-catenin, which subsequently downregulated its downstream targets, c-Myc and Cyclin D1. Furthermore, SELNs sensitized gastric cancer cells to cisplatin, demonstrating a synergistic suppression of Wnt pathway activity. In conclusion, this study revealed that SELNs exert multifaceted anti-gastric cancer effects by targeting the Wnt/β-catenin pathway and can sensitize cancer cells to chemotherapy, providing a novel natural nanotherapeutic strategy for gastric cancer treatment.